Summary
Latest filing:
Raymond Dwek files SEC Form 4 reports at UNITED THERAPEUTICS Corp (UTHR). 4 SEC Form 4 filings on record, most recently on 24 July 2025. Most recent open-market trade: sold $857K of UTHR on 21 April 2025. Lifetime open-market sales: $2.85M.
Recent transactions
6The latest 6 SEC Form 4 transactions reported by Raymond Dwek.
Trading pattern
InsiderAlpha's records for Raymond Dwek go back to 2025: 4 primary Form 4 filings, an average of 2.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Raymond Dwek files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Martine A. Rothblatt - $798.23M in UTHR purchases and sales in the last 12 months
- James Edgemond - $201.52M in UTHR purchases and sales in the last 12 months
- Michael Benkowitz - $135.23M in UTHR purchases and sales in the last 12 months
- Paul A. Mahon - $98.96M in UTHR purchases and sales in the last 12 months
- Christopher Patusky - $2.73M in UTHR purchases and sales in the last 12 months
- Ray Kurzweil - $2.40M in UTHR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Raymond Dwek?
Raymond Dwek is a corporate insider of UNITED THERAPEUTICS Corp (UTHR). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Raymond Dwek last file a Form 4?
The most recent primary Form 4 on record is dated 24 July 2025, one of 4 filings going back to 2025.
Has Raymond Dwek been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($2.85M) across all tracked filings.